Read More Pharma Industry News Can Genentech’s $50 direct-to-patient Xofluza launch reshape access to flu antivirals in 2025? Genentech slashes Xofluza price by 70% in a direct-to-patient launch with Amazon, Cost Plus, and Alto Pharmacy. See how this reshapes flu access in 2025. bySrinathOctober 16, 2025